Epicardial standalone left atrial appendage clipping for prevention of ischemic stroke in patients with atrial fibrillation contraindicated for oral anticaogulation

ConclusionThoracoscopic epicardial closure of the LAA with the AtriClip PRO2 device is a potentially safe and efficient treatment for stroke prevention in patients with NVAF contraindicated for anticoagulant or antiplatelet therapy.This article is protected by copyright. All rights reserved.

Source: Journal of Cardiovascular Electrophysiology - June 3, 2020 Category: Cardiology Authors: Stefano Branzoli, Massimiliano Marini, Fabrizio Guarracini, Carlo Pederzolli, Claudio Pomarolli, Giovanni D'Onghia, Maurizio Centonze, Mauro Fantinel, Francesco Corsini, Roberto Bonmassari, Angelo Graffigna, Mark La Meir Tags: ORIGINAL ARTICLES Source Type: research